Physician profile
Wade S Erickson
NPI 1245278183
$3,063.52
in general payments reported to CMS, 2019-2025
35 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $459 · 2021: $669 · 2022: $480 · 2023: $272 · 2024: $178 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $704.29 | 2019-2025 | |
| Astellas Pharma US INC | $223.73 | 2019-2023 | Veozah, Myrbetriq |
| Pfizer INC. | $211.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $209.10 | 2019-2020 | |
| Allergan, INC. | $183.33 | 2019-2020 | |
| Novo Nordisk INC | $183.11 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $113.65 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $100.72 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $96.18 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $95.75 | 2020-2025 | |
| Amgen INC. | $91.06 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.20 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $74.69 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.36 | 2021-2023 | Xifaxan, Trulance |
| Eisai INC. | $60.13 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $60.13 | 2019-2022 | |
| Amarin Pharma, INC. | $57.49 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.84 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $53.95 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $39.89 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.01 | 2019 | |
| Horizon Therapeutics Plc | $33.44 | 2021-2022 | |
| Csl Behring | $24.46 | 2019 | |
| Boston Scientific Corporation | $23.96 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.30 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.21 | 2022 | |
| Radius Health, INC. | $18.41 | 2021 | |
| Avanos Medical | $18.16 | 2025 | On-Q Pump and Accessories |
| Nevro Corp. | $18.00 | 2022 | |
| Hologic Sales and Service, LLC | $17.82 | 2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $17.59 | 2022 | |
| Genentech USA, INC. | $16.49 | 2021 | |
| Exact Sciences Corporation | $15.89 | 2023 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $14.25 | 2019 | |
| Alnylam Pharmaceuticals INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.